Cell Therapy & Bispecifics

A Curated Room: The People Shaping Practice

Now in its fifth year, this invitation-only meeting convenes a deliberately small faculty: 26 leading cell therapy and bispecific KOLs alongside 26 hand-selected fellows and junior faculty, the clinicians defining today’s standards and the ones who will define the next decade’s, in one room for two days.

The science tracks where treatment is moving: CAR T pushed earlier into first remission, T-cell engagers reshaping myeloma, and the sequencing questions that surface when one modality fails. Every session pairs expert talks with a moderated panel and a case presentation, sustained, close-quarters engagement rather than a lecture hall.